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ABSTRACT 
 
A study on the leaves of Aglaia exima led to the isolation of one new and seven known compounds.; six 
triterpenoids and two steroids. Their structures were elucidated and analyzed mainly by using 
spectroscopic methods; 1D and 2D NMR, mass spectrometry, UV spectrometry and X-ray. All the 
triterpenoids and steroids were measured in vitro for their cytotoxic activities against eight cancer cell 
lines; lung (A549), prostate (DU-145), skin (SK-MEL-5), pancreatic (BxPC-3), liver (Hep G2), colon 
(HT-29), breast (MCF-7) and (MDA-MB-231). The new cycloartane triterpenoid, cycloart-24-ene-3-one- 
26-ol 1, showed potent cytotoxic activity against colon (HT-29) cancer cell line (IC50 11.5 μM). 
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1.   Introduction 
 
The genus Aglaia is the largest genus of the family Meliaceae which has a total of 105 
species and is widely distributed in subtropical and tropical forest of southern mainland China, 
Indo-Malaysian region and the Pacific Island [1]. Meliaceae is a family known for the presence 
of triterpenes which possess interesting biological activities such as hypoglycemia, anticancer, 
anti-inflamatory,  antifeedant,  insecticides  and  antitumor activities  [2-3].  In  this  study,  eight 
compounds, including five cycloartane-type triterpenoids (1-5); cycloart-24-ene-3β,26-diol 1, 
cycloart-24-ene-3β,26-diol 2 [7,12], schizandronic acid 3 [9], 24(E)-3β-hydroxycycloart-24-ene- 
26-al 4  [10], vaticinone 5  [8], one dammarane-type triterpenoids; cabraleahydroxylactone 6 
[11,13], and two steroids (7-8); β-sitosterol 7 [4,5,6], stigmast-5-ene-28-one 8, were isolated 
from the leaves of  Aglaia exima (Fig. 1). We herein report the isolation and structure elucidation 
of the new cycloartane; cycloart-24-ene-3β,26-diol 1, together with the cyctotoxicities of 
compounds 1-7 against eight cancer cell lines, lung (A549), prostate (DU-145), skin (SK-MEL- 
5), pancreatic (BxPC-3), liver (Hep G2), colon (HT-29) and  breast (MDA-MB-231). 
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Fig. 1. The molecular structure of compounds 1-8 
 
 
2.   Experimental 
 
2.1 General 
 
The specific rotations were determined on Jasco P-1020 Polarimeter. UV spectra were 
measured  by  using  Shimazu  UV-  160A  ultraviolet-visible  spectrometer  with  methanol.  IR 
spectra were recorded by Perkin Elmer 1600 Series FT-NMR. 
1
H, 
13
C, DEPT, HSQC and HMBC 
NMR spectra were measured on JEOL JNM- LA 400 FT-NMR and JEOL ECA 400. Mass 
spectra were obtained by Shimadzu LCMS-IT-TOF Liquid Chromatograph Mass Spectrometer. 
Solvents were distilled prior to use, and spectroscopic grade solvents were employed. Column 
chromatography (CC) was carried out on Merck silica gel 60 (70-230 mesh and 230-400 mesh)
 and TLC on silica gel Merck 60 GF254. Spots on the plates were detected under UV light and 
visualized by spraying with vanillin reagent then followed by heating. 
2.2 Plant material 
 
The leaves of Aglaia exima was collected from H.S. Kg. Kepayang, Pahang, Malaysia on 
November 1997 and identified by Mr. Teo Leong Eng (University Malaya). Voucher specimen 
(KL 4762) has been deposited at the Herbarium of Department of Chemistry, University of 
Malaya, Kuala Lumpur, Malaysia. 
 
2.3 Plant extraction 
 
Dried ground leaves (1 kg) of Aglaia exima were extracted exhaustively with hexane at 
room temperature for 4 days and then filtered. The solution was decanted and then evaporated to 
give a residue of 25 g hexane extracts. 15 g of the hexane crude was subjected to column 
chromatography over silica gel using a gradient mixture of hexane and ethyl acetate as eluent. A 
total of 123 fractions were obtained and Fr. 54 gave crystals which is compound 7 (34.2 mg). 
Further isolation of Fr. 67 (ethyl acetate-hexane 86:14, 0.72 g) by CC with silica gel gave 5 (6.5 
mg), 1 (19.1 mg), 4 (25.6 mg) and 8 (5.1 mg). Fr. 94 to Fr. 100 (ethyl acetate- hexane 60:40 
50:50 20:80, 1.5398 g) were combined and further isolated by CC on silica gel to furnish 3 (16.3 
mg) and 6 (2.9 mg). Of 123 fractions, Fr. 92 was collected as crystals which were then 
recrystallized by ethyl acetate to give a colorless crystal 2 (93.6 mg). 
 
 
2.5 Spectroscopic data of compounds 
 
Compound 1. Colorless amorphous solid, +29.7o  (c 0.00209, CH2Cl2); IR (KBr): 3445, 
2942, 1705; UV (MeOH): 237 nm; HRESI-MS: m/z 463.3813 [M+Na]
+ 
calculated m/z 463.3678, 
1
H- and 
13
C- NMR data: see Table 1 
 
Compound 8. Colorless crystal;  -75.0o (c 0.00008, CH2Cl2); IR (KBr): 3419, 2934, 2852, 
1713 cm
-1
; UV (MeOH): 208 nm; EI-MS (m/z rel int): 428 m/z; 
1
H- and 
13
C- NMR data: see 
Table 1 
 
2.6 In vitro assay for cytotoxic activity 
 
2.6.1 Cell lines 
 
The hexane extract of the leaves from A. exima was investigated for cytotoxic activity 
against eight cancer cell lines; lung (A549), prostate (DU-145), skin (SK-MEL-5), pancreatic 
(BxPC-3), liver (Hep G2), colon (HT-29), breast (MCF-7) and (MDA-MB-231). These cancer 
cell lines were chosen from the National Cancer Institute (NCI) list of 60 cancer cell lines for 
drug screening and drug treatment conditions were done according to the NCI recommendations 
(Boyd,  1995).  The  human  cancer  cell  lines  were  obtained  from  American  Type  Culture 
Collection (ATCC) (Manassas, VA, USA). Dulbecco’s modified Eagle’s medium (DMEM), 100 
mM non-essential amino acids, phosphate buffer solution (pH 7.2), 50 µg/ml gentamycin and 2.5 
µg/ml amphotericin B were purchased from Invitrogen Corporation (Carlsbad, CA, USA). 200 
mM L-glutamine, foetal bovine serum, 0.25% trypsin-EDTA, dimethyl sulphoxide (DMSO),
 cisplatin and vinblastine sulphate were purchased from Sigma–Aldrich (St. Louis, MO, USA). 
MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl)-2H- 
tetrazolium, inner salt]   assay kit (CellTiter 96® AQueous  One Solution) was obtained from 
Promega (Madison, WI, USA). 
 
2.6.2 Cytotoxic assay 
 
Cell lines were cultured in DMEM media supplemented with 2 mM L-glutamine, 10% 
foetal bovine serum, 50 µg/ml gentamycin and 2.5 µg/ml amphotericin B, maintained in a 37 ºC 
humid atmosphere of 5% CO2 cell incubator. Samples and drug standards (cisplatin and 
vinblastine sulphate) were dissolved in DMSO and immediately diluted with DMEM media to 
yield a final DMSO concentration of less than 0.5% v/v. 
 
Cells were plated into 96-well microplates at 5,000–10,000 cells per well and maintained 
in the cell incubator for 24 hour. Then, 100 µL of samples were introduced in triplicates to a 
final concentration of 15–200 µM, with the exception of sample 1 that was further diluted down 
to 4 µM in BxPC-3 and HT-29 cell lines. Drug standards were also introduced to a final 
concentration of 0.03 - 2000 µM (cisplatin) and 0.002 - 100 µM (vinblastine sulphate). Cells 
were further incubated for 48 hours and then, cell viability was determined according to the 
manufacturer protocol of a commercial MTS assay kit (CellTiter 96 AQueous® One Solution, 
Promega). Culture media were carefully refreshed with 100 µL of DMEM media, followed by 20 
µL per well of MTS reagent. Microplates were returned to the incubator for 1 to 2 hours and 
absorbance of the formazan product was read on a microplate reader at 490nm with 690nm as the 
background wavelength (Infinite 200, Tecan, Männedorf, Swizerland). IC50 of samples and drug 
standards were determined using dose-response curves in Prism 5.02 software (GraphPad 
Software Inc., La Jolla, CA, USA). 
 
3.   Results and discussion 
 
Compound 1, was obtained as colorless amorphous solid,  +29.7
o 
(c 0.00209, CH2Cl2). 
The  HR-ESI-MS spectrum showed an [M+Na]
+  
pseudomolecular ion peak at m/z 463.3813 
(calcd 463.3678) which corresponded to the molecular formula of C30H48O2. The IR spectrum 
showed absorption peaks at 3445, 2942, 1705cm
-1 
suggesting the presence of hydroxyl, alkyl and 
carbonyl groups respectively. The cycloartane nature of 1 was deduced by the appearance of a 
pair of very shielded doublets at δ 0.58 and 0.79 (J = 4.4 Hz).   The olefinic proton (H-24) 
resonated as a broad triplet at δ 5.36 (J= 7.1 Hz). ). In addition, the oxymethylene protons which 
were attached to C-26 appeared as a broad singlet at δ 3.94. The 13C NMR and DEPT spectra 
showed peaks corresponding to thirty carbons; six methyl, twelve methylene, five methine, and 
seven quaternary carbons. The peak at δ 216.7 is assignable to the ketonic carbonyl, C-3. In 
addition, the signals of the double bond carbons (C-24, C-25) appeared at δ 127.0 and δ 134.3 
respectively. The methylene carbon C-26 of the side chain resonated downfield at δ 69.0 since it 
is attached to a hydroxyl group. The HMBC spectrum showed correlations of H-24 with C-26 
and C-27, H-26 with C-24, C-25 and C-27 thus confirming the position of the double bond at C- 
24 and C-25 respectively. Furthermore, the location of the hydroxyl group on C-26 was also 
established by the HMBC correlations of H2-26 with C-24, 25 and C-27. Thorough analysis of 
the DEPT, COSY, HSQC and HMBC spectra allowed the complete assignment of all protons 
and carbons (Table 1). Therefore, compound 1 was elucidated as cycloart-24-ene-3β,26-diol.
 Compounds 2-7 were isolated by comparison of their NMR data with literature values, 
known compounds 2-7 were identified as cycloart-24-ene-3β,26-diol 2 [7,12], schizandronic acid 
3 [9], 24(E)-3β-hydroxycycloart-24-ene-26-al 4 [10], vaticinone 5 [8], cabraleahydroxylactone 6 
[11,13] and β-sitosterol 7 [4,5,6]. Compound 8 is a new natural product. It was previously 
synthesized by Ikekawa et.al. The complete proton and carbon assignments of 8 are listed in 
Table 1. 
 
Table 1 
   1
H and 
13
C NMR of Compound 1 and 8 in CDCl3              
             Position                                   δH  (p p m)                                δC  (p p m)                          δH  (p p m)                           δC  (p 
p m)   
 
1 
 
2 
1.48 (m) 
1.78 (m) 
2.30 (m) 
 33.4 
 
37.4 
 1.06 (m) 
1.79 (m) 
1.80 (m) 
 37.3 
 
31.7 
 
 
3 
2.70 (ddd, J1= 7.3 Hz, J2= 13.9 
Hz, J3= 21.2 Hz) 
- 
  
 
216.7 
  
 
3.50 (m) 
  
 
71.9 
4 -  50.2  2.21 (m)  42.4 
5 1.52 (m)  48.4  -  140.8 
6 1.50 (m)  21.5  5.32 (d, J= 6.9 Hz)  121.8 
7 1.22 (m)  28.1  1.44 (m)  32.0 
 1.84 (m)    1.92 (m)   
8 1.64 (m)  47.8  1.44 (m)  32.0 
9 -  21.1  0.89 (m)  50.1 
10 -  25.9  -  36.5 
11 1.10 (m)  26.7  1.40 (m)  21.1 
 1.98 (m)    1.44 (m)   
12 1.60 (m)  32.8  1.10 (m)  39.8 
     1.96 (m)   
13 -  45.3  -  42.4 
14 -  48.7  0.96 (m)  55.9 
15 1.02 (m)  35.9  0.98 (m)  24.3 
     1.52 (m)   
16 1.86 (m)  24.5  1.14 (m)  28.2 
 2.02 (m)    1.74 (m)   
17 -  52.2  1.04 (m)  55.8 
18 1.00 (s)  18.1  0.70 (s)  11.9 
19 0.58 (d, J= 4.4 Hz)  29.5  1.00 (s)  20.1 
 0.79 (d, J= 4.4 Hz)       
20 1.02 (m)  35.9  1.32 (m)  35.9 
21 0.91 (d, J= 6.1Hz)  18.2  0.91 (d, J= 2.0 Hz)  18.5 
22 1.24 (m)  35.5  0.88 (m)  33.9 
     1.20 (m)   
23 1.08 (m)  25.8  1.32 (m)  25.4 
 1.30 (m)    1.54 (m)   
24 5.36 (t, J1= 7.1 Hz)  127.0  2.11 (d, J= 6.9 Hz)  60.6 
25 -  134.3  1.78 (m)  30.2 
26 3.94 (s)  69.0  0.87 (d, J= 2.2 Hz)  21.3 
27 1.68 (s)  13.6  0.89 (d, J= 2.2 Hz)  20.1 
28 1.05 (s)  22.2  -  213.5 
29 1.10 (s)  20.7  2.09 (s)  30.0 
30 0.91 (s)  19.3     
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Fig. 2. Selected HMBC correlations of Compound 1 
 
Colon (HT-29) cancer cell line was found to be very susceptible towards cycloart-24-ene- 
3-one-26-ol 1 with IC50 values of 11.48 μg/ml. Meanwhile, cycloart-24-ene-3-one-26-ol 1 
revealed moderate to skin (SK-MEL-5) and breast (MCF-7). Cycloart-24-ene-3β,26-diol 2 shows 
moderate effect against liver (Hep G2) and colon (HT-29), weak against lung (A549), skin (SK- 
MEL-5), breast (MCF-7) and (MDA-MB-231). Vaticinone 5 revealed moderate inhibitory effect 
towards colon (HT-29) and weak towards skin (SK-MEL-5). At last, 24(E)-3β-hydroxycycloart- 
24-ene-26-al 4 has moderate effect against breast (MDA-MB-231) and weak against skin (SK- 
MEL-5). schizandronic acid 3, cabraleahydroxylactone 6, β-sitosterol 7 and stigmast-5-ene-28- 
one 8 exhibited no significant inhibitory effects with IC50 values over 200 μM. 
 
 
 
Table 2. 
Cytotoxicity of Eight Compounds for Eight Cancer Cell Linesa 
 
Name of Compounds A549 DU- 
145 
SK- 
MEL-5 
BxPC 
-3 
Hep 
G2 
HT- 
29 
MCF- 
7 
MDA- 
MB-231 
Cycloart-24-ene-3-one-26-ol 1 - - 96.6 - - 11.5 86.2 - 
Cycloart-24-ene-3β,26-diol 2 172.4 - 157.8 - 75.1 99.3 127.7 195.2 
Schizandronic acid 3 - - - - - - - - 
24(E)-3β-hydroxycycloart-24-ene-26- 
al 4 
Vaticinone 5 
- 
 
- 
- 
 
- 
117.8 
 
105.7 
- 
 
- 
- 
 
- 
- 
 
96.8 
- 
 
- 
94.4 
 
- 
Cabraleahydroxylactone 6 - - - - - - - - 
β- sitosterol 7 - - - - - - - - 
Stigmast-5-ene-28-one 8 - - - - - - - - 
a 
Results are expressed as IC50 values in μM . Blank indicates IC50 more than 200 μM 
 
 
Table 3. 
Cyctotoxicity of Drug Standards against Eight Cancer Cell Lines   
Drug standards 
(Mean ± SD, n=3) 
               Cisplatin                              Vinblastine   
Lung (A549)                           36.17 ± 3.00 µM                   29.01 ± 6.46 µM 
Prostate (DU-145)                       12.54 ± 0.50 µM                    4.75 ± 1.13 µM 
 
Skin (SK-MEL-5)                       68.86 ± 1.13 µM                    1.71 ± 0.24 µM
  
Pancreatic (BxPC-3) 
Liver (Hep G2) 
 
22.10 ± 0.31 µM 
 
15.20 ± 1.04 µM 
 
2.03 ± 1.05 µM 
 
0.35 ± 0.41 µM 
Colon (HT-29) 
Breast (MCF-7) 
Breast (MDA-MB-231) 
70.19 ± 2.21 µM 
 
90.11 ± 2.11 µM 
 
306.73 ± 3.45 µM 
0.98 ± 0.33 µM 
 
28.11 ± 3.20 µM 
 
35.32 ± 3.42 µM 
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Table 1 
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Hz, J3= 21.2 Hz) 
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71.9 
4 -  50.2  2.21 (m)  42.4 
5 1.52 (m)  48.4  -  140.8 
6 1.50 (m)  21.5  5.32 (d, J= 6.9 Hz)  121.8 
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14 -  48.7  0.96 (m)  55.9 
15 1.02 (m)  35.9  0.98 (m)  24.3 
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17 -  52.2  1.04 (m)  55.8 
18 1.00 (s)  18.1  0.70 (s)  11.9 
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 1.30 (m)    1.54 (m)   
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25 -  134.3  1.78 (m)  30.2 
26 3.94 (s)  69.0  0.87 (d, J= 2.2 Hz)  21.3 
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Table 2. 
Cytotoxicity of Eight Compounds for Eight Cancer Cell Linesa 
 
Name of Compounds A549 DU- 
145 
SK- 
MEL-5 
BxPC 
-3 
Hep 
G2 
HT- 
29 
MCF- 
7 
MDA- 
MB-231 
Cycloart-24-ene-3-one-26-ol 1 - - 96.6 - - 11.5 86.2 - 
Cycloart-24-ene-3β,26-diol 2 172.4 - 157.8 - 75.1 99.3 127.7 195.2 
Schizandronic acid 3 - - - - - - - - 
24(E)-3β-hydroxycycloart-24-ene-26- - - 117.8 - - - - 94.4 
al 4 
Vaticinone 5 
 
- 
 
- 
 
105.7 
 
- 
 
- 
 
96.8 
 
- 
 
- 
Cabraleahydroxylactone 6 - - - - - - - - 
β- sitosterol 7 - - - - - - - - 
Stigmast-5-ene-28-one 8 - - - - - - - - 
a
Results are expressed as IC50 values in μM . Blank indicates IC50 more than 200 μM
 Table 3. 
Cyctotoxicity of Drug Standards against Eight Cancer Cell Lines   
Drug standards 
(Mean ± SD, n=3) 
               Cisplatin                              Vinblastine   
 
Lung (A549) 
Prostate (DU-145) 
Skin (SK-MEL-5) 
Pancreatic (BxPC-3) 
 
36.17 ± 3.00 µM 
 
12.54 ± 0.50 µM 
 
68.86 ± 1.13 µM 
 
22.10 ± 0.31 µM 
 
29.01 ± 6.46 µM 
 
4.75 ± 1.13 µM 
 
1.71 ± 0.24 µM 
 
2.03 ± 1.05 µM 
Liver (Hep G2) 
 
Colon (HT-29) 
15.20 ± 1.04 µM 
 
70.19 ± 2.21 µM 
0.35 ± 0.41 µM 
 
0.98 ± 0.33 µM 
Breast (MCF-7) 
 
Breast (MDA-MB-231) 
90.11 ± 2.11 µM 
 
306.73 ± 3.45 µM 
28.11 ± 3.20 µM 
 
35.32 ± 3.42 µM 
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Fig. 1. The molecular structure of compounds 1-8 
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Fig. 2. Selected HMBC correlations of Compound 1 
